Biography/Memoir

Wuhan [China] signs letter of intent with Biodelta [South Africa] one month after launching psilocybin division

Although the psilocybin industry is still in its nascent stages, all signs suggest that the momentum behind developing psychedelic medicines will continue to grow.  As James Hamblin recently wrote in The Atlantic, “The growth of cannabis is a reminder that once there is money to be made, industries form lobbies in Washington, D.C., and it becomes…

READ MORE
Biography/Memoir

Pushes to make it easier to study [psilocybin-containing] mushrooms and other psychedelic drugs

Legislation [was introduced] on Friday, June 10, 2019 to remove a legal barrier that scientists say makes it unnecessarily difficult for them to study the medical benefits of psychedelic drugs like psilocybin and MDMA. “Academics and scientists report that provisions like this create [stigma] and insurmountable logistical hurdles to researching schedule I drugs,” the summary…

READ MORE
Biography/Memoir

Leading U.S. prosecutors visit Portugal to learn about drug decriminalization

Twenty prosecutors from major cities across the U.S. are touring Portugal this month to learn about the successful implementation of the country’s drug decriminalization law. In Portugal, where all drugs were decriminalized in 2001, the prosecutors will observe the impacts of that nationwide policy, which according to research has reduced incarceration rates and improved public health…

READ MORE